-
Prana Biotechnology Limited (ADR) (NASDAQ: PRAN)
shares climbed 55.5 percent to $3.86.
-
Extreme Networks, Inc (NASDAQ: EXTR) shares
jumped 21.4 percent to $7.84 after the company announced plans to acquire Brocade's data center networking business for $55
million.
-
Celyad SA (ADR) (NASDAQ: CYAD) shares gained 21.4
percent to $24.90.
-
BiondVax Pharmaceuticals Ltd (ADR) (NASDAQ: BVXV)
surged 18.9 percent to $6.74 after the company disclosed that it has been approved for a grant from Israel's Ministry of
Economy and Industry to build a facility for commercial scale production of its universal flu vaccine candidate M-001.
-
NQ Mobile Inc (ADR) (NYSE: NQ) shares rose 14.4
percent to $4.38 after the company reported a deal to close FL Mobile divestment and for the sale of Showself's live social
video business.
-
Interpace Diagnostics Group Inc (NASDAQ: IDXG)
shares climbed 13.7 percent to $2.90. Interpace Diagnostics reported Q4 earnings from continuing operations of $3.25 per share
on revenue of $3.122 million.
-
Acasti Pharma Inc (NASDAQ: ACST) shares rose 13.5
percent to $1.43 after the company announced plans to proceed with Phase 3 CaPRe program following recent end-of-Phase 2
meeting with the FDA.
-
HTG Molecular Diagnostics Inc (NASDAQ: HTGM)
shares gained 13.1 percent to $7.41 after declining 10.27 percent on Wednesday.
-
AEterna Zentaris Inc. (USA) (NASDAQ: AEZS) shares
rose 7.2 percent to $3.11. Aeterna Zentaris disclosed that it intends to file a NDA with respect to Macrilen in the third
quarter.
-
Anthera Pharmaceuticals Inc (NASDAQ: ANTH) gained
6.3 percent to $0.457 after the company reported positive results from the Extension Period of SOLUTION study of Sollpura.
-
ConocoPhillips (NYSE: COP) rose 6 percent to $48.68
after Cenovus Energy agreed to acquire Conocophillips 50 percent interest in FCCL partnership for $17.7 billion. UBS upgraded
ConocoPhillips from Neutral to Buy.
-
Galectin Therapeutics Inc (NASDAQ: GALT) shares
gained 5.1 percent to $2.08. H.C. Wainwright upgraded Galectin Therapeutics from Neutral to Buy.
-
Omeros Corporation (NASDAQ: OMER) rose 4.8
percent to $15.23 after the company reported data in OMS721 Phase 2 trial in renal diseases.
-
Lindsay Corporation (NYSE: LNN) shares rose 3.2
percent to $83.99 after the company posted upbeat quarterly results.
-
Kingold Jewelry Inc (NASDAQ: KGJI) shares gained
2.6 percent to $1.29. Kingold Jewelry reported Q4 earnings of $0.63 per share on revenue of $357.6 million.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.